A detailed history of Kingdon Capital Management, L.L.C. transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 121,706 shares of SLGL stock, worth $79,108. This represents 0.01% of its overall portfolio holdings.

Number of Shares
121,706
Previous 481,749 74.74%
Holding current value
$79,108
Previous $472,000 77.12%
% of portfolio
0.01%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.66 - $1.05 $237,628 - $378,045
-360,043 Reduced 74.74%
121,706 $108,000
Q1 2024

May 15, 2024

SELL
$0.95 - $1.5 $183,515 - $289,761
-193,174 Reduced 28.62%
481,749 $472,000
Q4 2023

Feb 14, 2024

SELL
$0.92 - $1.6 $84,580 - $147,096
-91,935 Reduced 11.99%
674,923 $742,000
Q3 2023

Nov 14, 2023

SELL
$1.63 - $3.94 $6,694 - $16,181
-4,107 Reduced 0.53%
766,858 $1.25 Million
Q1 2023

May 15, 2023

SELL
$3.44 - $5.32 $212,712 - $328,962
-61,835 Reduced 7.42%
770,965 $2.99 Million
Q3 2020

Nov 16, 2020

BUY
$7.15 - $8.73 $23,595 - $28,809
3,300 Added 0.4%
832,800 $6.03 Million
Q1 2020

May 15, 2020

BUY
$5.88 - $15.75 $1.52 Million - $4.07 Million
258,118 Added 45.17%
829,500 $5.86 Million
Q3 2019

Nov 14, 2019

BUY
$7.7 - $10.48 $2.01 Million - $2.73 Million
260,788 Added 83.96%
571,382 $5.14 Million
Q2 2019

Aug 14, 2019

BUY
$6.78 - $9.49 $478,973 - $670,421
70,645 Added 29.44%
310,594 $2.83 Million
Q4 2018

Feb 14, 2019

BUY
$5.79 - $8.1 $87,683 - $122,666
15,144 Added 6.74%
239,949 $1.44 Million
Q3 2018

Nov 14, 2018

BUY
$6.2 - $7.8 $220,403 - $277,282
35,549 Added 18.78%
224,805 $1.69 Million
Q2 2018

Aug 14, 2018

BUY
$7.5 - $10.71 $25,650 - $36,628
3,420 Added 1.84%
189,256 $1.46 Million
Q1 2018

May 15, 2018

BUY
$10.3 - $13.64 $1.91 Million - $2.53 Million
185,836 New
185,836 $1.91 Million

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $15M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Kingdon Capital Management, L.L.C. Portfolio

Follow Kingdon Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.